Navigation Links
Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
Date:1/8/2009

ncer cells acquire multiple mutations that disable their normal response to apoptotic triggers. AEG35156, a second generation antisense which targets XIAP, is designed to lower the apoptotic threshold of cancer cells, enhancing their sensitivity to intrinsic death and chemotherapy, without harming healthy cells. Aegera's published data with AEG35156, both in vitro and in vivo, strongly supports this hypothesis, and validates XIAP as a novel drug target for the development of anti-cancer therapeutics.

About Aegera Therapeutics Inc.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing novel targeted therapies that address major unmet medical needs. In addition to AEG35156, Aegera has two additional programs in clinical development for the treatment of cancer and neuropathic pain. Details of these programs can be found on Aegera's website at www.aegera.com.


'/>"/>
SOURCE AEGERA THERAPEUTICS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Aegera Therapeutics phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting
2. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
3. Aegera Therapeutics welcomes two experienced executives to its board of directors
4. Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain
5. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
6. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
7. Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market
8. Horizon Therapeutics Announces Senior Management Appointments
9. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
10. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
11. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., HOUSTON, Dec. 3 JourneyLite o...d its facility to offer patients a second surgical... the LAP-BAND® System that it currently per...he facility was performed by surgeon partner, Mat...ient is reported as doing well. ,, The Vertical...
(Date:12/3/2009)...PHILADELPHIA, Dec. 3 Shi...cialty biopharmaceutical company, today announced ...et withdrawal of one lot of the Attention-Deficit/...; . Shire is taking this action because some Daytr...eet their release liner removal specification, and...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswire-As... Officer at Shenzhen Beike Biotechnology Co. Ltd.,...rence on High-Risk Diabetic,Foot Care in New Delhi...ng,stem cell research and regenerative medicine co... Indian Podiatry Association (IPA), aimed,to help ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlinke...is available in its catalogue: ,, Carbondioxid... http://www.reportlinker.com/p0164368/Carbondioxid...,, Incubators are the most critical equipment u...nd other applications for providing a controlled e...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
... The American Filtration ... 22nd Annual Conference, May 4-7, 2009 at the Sher... Minneapolis, MN (PRWEB) April 7, 200...ety (AFS) will be holding its 22nd Annual Confere...ngton Minnesota. Dr. David Y.H. Pui, Distinguishe...
... SYDNEY, April 6 /PRNewswire-Asia/ -- Pharmaceu...) today announced the appointment of the U.S. life...to its Board of Directors. , Mr van den Broek ...LC, a,U.S. based fund manager with an investment e...ies. HSMR Advisors has held a position on the Pha...
...TUCSON, Ariz., and GILROY, Calif., April 6 The De... College of Medicine and OmegaGenesis, Inc., annou...dies to address diabetic foot ulcers. , , The a...al remedies and to identify effective ways to prov...nals and patients globally. , , Diabetic foot ulc...
Other Biology Technology:University of Minnesota Professor Dr. David Pui to Speak at American Filtration and Separation Society Conference 2University of Minnesota Professor Dr. David Pui to Speak at American Filtration and Separation Society Conference 3New Pharmaxis Board Appointment 2The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers 2The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers 3The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers 4
(Date:12/3/2009)... Forest dwellers must be included in the design o...to avoid a humanitarian crisis, according to a sci...day in Nature , Dr Simon Lewis argues that at lea...at Copenhagen, known as REDD (Reducing Emissions f... to forest dwellers directly, and their property r...
(Date:12/2/2009)... , PHILADELPHIA Children exposed to secondhand c...g lung cancer in adulthood, even if they never smo...Cancer Epidemiology, Biomarkers & Prevention , a j...arch, as part of a special tobacco focus in the De...000 Americans will be diagnosed with lung cancer; ...
(Date:12/2/2009)... , PHILADELPHIA Mexican-American adolescents exp...e likely to pick up the habit themselves, and this...ed with smoking initiation, according to new study... smoking in the United States and highlights the g...ion Framework Convention on Tobacco Control, which...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Microsoft Rogue Internet Pharmacy Problem Fixed 3F Not So Fast Say Researchers 54512 1Microsoft Rogue Internet Pharmacy Problem Fixed 3F Not So Fast Say Researchers 54512 2Orchids and fungi partners for life 9571 1First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 1First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 2
... phage display technique successful in identifying...sistance , A simple, harmless virus might hold th...ent of HIV and anti-viral drugs, UCI chemical biol...ompounds that can outmaneuver a virus, effort to m...ewski employed this virus, called a bacteriophage,...
...ritical lock and key mechanism that allows the fin...ation has been identified by a University of Calif... research that promises to lead to a new way to ha...ply. , The research team led by Judith Varner, Ph....member of the Rebecca and John Moores UCSD Cancer ...
...rug first used to reduce the risk of stomach ulcer...fers an alternative to surgery after miscarriage, ...l Institute of Child Health and Human Development ...earch institutions. , The study appears in the Au...The drug, misoprostol, has been used to reduce the...
Other Biology News:Harmless virus may hold key to more effective HIV drug discovery 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 3Sleeping Sickness Epidemic Spreading in Uganda 2Sleeping Sickness Epidemic Spreading in Uganda 3Sleeping Sickness Epidemic Spreading in Uganda 4
Mouse Anti-Human PMM2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rhodamine 110 (Fluorescence Reference Standard) from AnaSpec
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Mouse Anti-Human PPOX Monoclonal Antibody, Unconjugated, Clone 2F10 from ABR-Affinity BioReagents
Biology Products: